Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children
Conditions
Interventions
BioGaia Pharax (L. reuteri PTA 5289 and DSM 17938)
Placebo
Locations
1
Hungary
Szent Miklós Szolgálat Kft.
Szigetszentmiklós, Pest County, Hungary
Start Date
December 21, 2023
Primary Completion Date
November 30, 2025
Completion Date
November 30, 2025
Last Updated
January 16, 2024
Lead Sponsor
Milosevits Gergely
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions